Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II

INTRODUCTION: Since its approval for adults with moderate-to-severe atopic dermatitis (AD) in 2017, dupilumab has been incorporated into clinical practice guidelines (CPGs). However, recommendations differ internationally, and the quality assessment of their development is unclear. OBJECTIVE: We aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghazal, Stephanie, Ridha, Zainab, D'Aguanno, Kathleen, Nassim, David, Quaiattini, Andrea, Netchiporouk, Elena, Poulin, Yves, Kalia, Sunil, Marcoux, Danielle, Piguet, Vincent, Jack, Carolyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959491/
https://www.ncbi.nlm.nih.gov/pubmed/35355606
http://dx.doi.org/10.3389/fmed.2022.821871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959491/
https://www.ncbi.nlm.nih.gov/pubmed/35355606
http://dx.doi.org/10.3389/fmed.2022.821871

Ejemplares similares